Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Endo Appoints New CMO

This article was originally published in Scrip

Executive Summary

Endo International Plc has named Craig Paterson chief medical officer. Paterson will be responsible for the company's global clinical development strategies and lifecycle management. Before joining Endo, Paterson was senior vice-president of medical and clinical development for Salix Pharmaceuticals and he has held roles within medical and clinical development at GlaxoSmithKline plc and King Pharmaceuticals, a wholly owned subsidiary of Pfizer Inc.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register